Understanding cancer

Cancer as a metabolic disease

Cancer is a complex disease, and no single model explains every aspect of its behavior. Traditionally viewed as a genetic disease, growing research suggests metabolic dysfunction also plays a critical role, guiding strategies that may complement conventional treatment.

1931

The Warburg Effect

Otto Warburg received the Nobel Prize for discovering that cancer cells rely heavily on fermentation of glucose for energy, even when oxygen is available. Healthy cells primarily use oxidative phosphorylation within the mitochondria.

The role of mitochondria

When mitochondrial function is impaired, cells shift toward fermentation. This may contribute to:

Increased reliance on glucose
Altered cellular signaling
Increased oxidative stress
Changes in cell growth regulation

Glucose and glutamine

Cancer cells often rely on glucose and glutamine. Many normal cells retain the ability to use fatty acids and ketone bodies, an important metabolic flexibility.

Why this matters

Nutritional approaches (ketogenic strategies)
Fasting protocols
Targeting metabolic pathways
Supporting mitochondrial health

Metabolic therapy in practice

Supporting metabolic flexibility
Reducing excessive glucose exposure
Carefully incorporating fasting when appropriate
Targeted therapies that affect metabolic pathways

A balanced perspective

Cancer is not solely a metabolic nor solely a genetic disease, it is likely both. An integrative approach considering genetics, metabolism, immune function and environment may offer the most comprehensive understanding.